Top Stories
- Immunize.org updates more of its 2026–27 suite of influenza vaccination resources
- FDA licenses updated COVID-19 vaccines; healthcare professional organization recommendations anticipated September 2
- Immunize.org reviews and updates Ask the Experts web section on varicella vaccination
- Immunize.org updates popular handout, “Tips for Locating Old Immunization Records”
- Measles 2026: two measles-associated deaths reported by Pennsylvania; MMWR describes measles transmission trends
- “Introducing VaccineInformation.org”: the new 4-minute video, part of the Orientation Video Series on YouTube
- Vaccines in the news
Immunize.org Website and Clinical Resources
- Summary: these updated Immunize.org materials were released during July and August
- Recap: Immunize.org and Association of Immunization Managers update “Communicating the Benefits of Influenza Vaccination” for the 2026–27 season
- Recap: Immunize.org reviews and updates Ask the Experts web section on measles, mumps, rubella, and MMR vaccination
Featured Resources
- Preparing for influenza season? Need VIS translations? Download and print Immunize.org’s free QR code table that links directly to all injectable influenza VIS translations
- From the Immunize.org shop! Laminated VIS QR code tables deliver CDC VISs directly to your patients’ smartphones (Spanish translation available).
- Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations
- Recap: Most states resume offering RSV vaccination during pregnancy weeks 32 through 36 on September 1 and prepare to resume immunization of eligible infants and toddlers with RSV preventive antibodies by October
Notable Publications
- “HPV Vaccination and Risk of Head and Neck Cancers: A Large Real-World Cohort Study” published in International Journal of Infectious Diseases
- “Heterogeneity Among the Vaccine Hesitant: A Secondary Analysis of the National CEAL Common Survey Data” published in Vaccine
- “Cardiac outcomes following SARS-CoV-2 infection versus BNT162b2 vaccination in adolescents and young adults: a cohort study of 4 million individuals” published in Vaccine